首页|无创正压通气联合呼吸兴奋剂治疗慢性阻塞性肺疾病急性呼吸衰竭的效果分析

无创正压通气联合呼吸兴奋剂治疗慢性阻塞性肺疾病急性呼吸衰竭的效果分析

扫码查看
目的 探讨无创正压通气联合呼吸兴奋剂在慢性阻塞性肺疾病急性呼吸衰竭患者中的效果。方法 选择 2021 年 3 月~2023 年6 月慢性阻塞性肺疾病急性呼吸衰竭患者 94 例为对象,随机数字表法分为两组各 47 例。对照组采用药物(呼吸兴奋剂)+氧疗,治疗组在对照组基础上联合无创呼吸机治疗,两组治疗 3 d及 7 d评估患者效果,比较两组呼吸、神志、心率、血气、C反应蛋白(CRP)变化、病死率及安全性。结果 两组治疗 7 d后患者呼吸、神志、心率及CRP水平得到改善;观察组呼吸、心率及CRP水平低于对照组(P<0。05);神志评分高于对照组(P<0。05);两组治疗 7 d后pH水平差异无统计学意义(P>0。05);观察组PaO2 水平高于对照组(P<0。05);PaCO2水平低于对照组(P<0。05);观察组治疗 7 d后病死率低于对照组(P<0。05);两组再次插管、误吸、谵妄、恶心呕吐发生率差异无统计学意义(P>0。05)。结论 无创正压通气联合呼吸兴奋剂用于慢性阻塞性肺疾病急性呼吸衰竭患者中,能改善患者呼吸、神志、心率及血气水平,可降低CRP水平,获得良好的预后,不增加不良反应发生率。
Effect of noninvasive positive pressure ventilation combined with respiratory stimulants on acute respiratory failure in patients with chronic obstructive pulmonary disease
Objective To investigate the effect of noninvasive positive pressure ventilation combined with respiratory stimulants in patients with acute respiratory failure caused by chronic obstructive pulmonary disease.Methods From March 2021 to June 2023,94 patients with acute respiratory failure caused by chronic obstructive pulmonary disease were selected as subjects.They were randomly divided into two groups with 47 cases in each group.The control group was treated with drugs(respiratory stimulants)and oxygen therapy,while the treatment group was treated with non-invasive ventilation on the basis of the control group.The efficacy of the two groups was evaluated for 3 and 7 days of treatment,and changes in breathing,consciousness,heart rate,blood gas,C-reactive protein(CRP),mortality rate,and safety were compared between the two groups.Results After 7 days of treatment,the respiratory,mental,heart rate,and CRP levels of patients in both groups improved;The respiratory,heart rate,and CRP levels in the observation group were lower than those in the control group(P<0.05);The mental state score was higher than that of the control group(P<0.05);There was no statistically significant difference in pH levels between the two groups after 7 days of treatment(P>0.05);The PaO2 level in the observation group was higher than that in the control group(P<0.05);The level of PaCO2 was lower than that of the control group(P<0.05);The mortality rate of the observation group after 7 days of treatment was lower than that of the control group(P<0.05);There was no statistical difference in the incidence of reintubation,aspiration,delirium,and nausea and vomiting between the two groups(P>0.05).Conclusion Non invasive positive pressure ventilation combined with respiratory stimulants in patients with acute respiratory failure caused by chronic obstructive pulmonary disease can improve the level of respiration,consciousness,heart rate and blood gas,reduce the level of CRP,obtain good prognosis,and do not increase the incidence of adverse reactions.

Non-invasive positive pressure ventilationRespiratory stimulantsChronic obstructive pulmonary diseaseAcute respiratory failureC-reactive protein

梁润泽、韦晓婷

展开 >

阳江市人民医院呼吸与危重症医学科,广东阳江 529500

无创正压通气 呼吸兴奋剂 慢性阻塞性肺疾病 急性呼吸衰竭 C反应蛋白

阳江市卫生健康局科技项目(2021)

阳卫健2021025

2024

中国处方药
南方医药经济研究所

中国处方药

影响因子:0.649
ISSN:1671-945X
年,卷(期):2024.22(3)
  • 20